176 results on '"Gouraud, Wilfried"'
Search Results
2. Intérêt de l’outil web bc-GenExMiner en oncologie
3. Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches
4. Supplementary Data from Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
5. Data from Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
6. Supplementary Table 3 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
7. Supplementary Table 4 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
8. Supplementary Figures from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
9. Supplementary Table 2 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
10. Supplementary Table 1 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
11. Abstract P5-02-37: Multi-omics approach to identify markers of resistance to endocrine therapy + CDK4/6 inhibitors in first line HR+/HER2- metastatic breast cancer (MBC) patients
12. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
13. Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
14. Molecular screening of interleukin-6 gene promoter and influence of −174G/C polymorphism on breast cancer
15. bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer
16. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial
17. Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen
18. bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses
19. Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches
20. Inhibition of mTORC1 activity by REDD1 induction in myeloma cells resistant to bortezomib cytotoxicity
21. Molecular characterization of the response to chemotherapy in conventional osteosarcomas: Predictive value of HSD17B10 and IFITM2
22. Additional file 18: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
23. Additional file 29: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
24. Additional file 5: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
25. Additional file 3: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
26. Additional file 4: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
27. Additional file 9: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
28. Additional file 6: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
29. Additional file 7: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
30. Additional file 8: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
31. RUBY: A phase II study testing rucaparib in germline (g) BRCA wild-type patients presenting metastatic breast cancer (mBC) with homologous recombination deficiency (HRD).
32. iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors
33. c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1
34. A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Multiple Myeloma Patients
35. Logic programming reveals alteration of key transcription factors in multiple myeloma
36. An open-label, phase II study of rucaparib, a PARP inhibitor, in HER2- metastatic breast cancer patients with high genomic loss of heterozygosity: RUBY.
37. Additional file 6: of Gene-expression signature functional annotation of breast cancer tumours in function of age
38. Additional file 5: of Gene-expression signature functional annotation of breast cancer tumours in function of age
39. Additional file 8: of Gene-expression signature functional annotation of breast cancer tumours in function of age
40. Additional file 1: of Gene-expression signature functional annotation of breast cancer tumours in function of age
41. Additional file 9: of Gene-expression signature functional annotation of breast cancer tumours in function of age
42. Additional file 2: of Gene-expression signature functional annotation of breast cancer tumours in function of age
43. Additional file 7: of Gene-expression signature functional annotation of breast cancer tumours in function of age
44. Additional file 4: of Gene-expression signature functional annotation of breast cancer tumours in function of age
45. Additional file 3: of Gene-expression signature functional annotation of breast cancer tumours in function of age
46. A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
47. Gene-expression signature functional annotation of breast cancer tumours in function of age
48. Abstract P2-04-07: Gene-expression molecular subtyping of immunohistochemistry-typed triple-negative breast cancer tumours
49. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
50. A Genome Wide Association Study Reveals Genetic Predisposition for Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma By Variation in the PREP1-Cbs Locus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.